SYNDROMIC DEAFNESS AND CONNEXIN HEMICHANNEL DYSFUNCTION
Permanent childhood deafness occurs with an incidence of ~1.5 cases per 1000 live births. Approximately 30% of deaf children have cognitive impairment due to the loss of functional interactions among the sensory systems. Although there are a number of genes associated with inherited deafness, mutation of the GJB2 gene encoding the Cx26 gap junction (GJ) protein is the most common. In addition to cognitive impairment and slowed development, there is growing evidence that some Cx26 mutations are linked to developmental cerebellar anomalies. Our studies are currently focusing on a subset of GJB2 mutations that lead to syndromic forms of deafness in which sensorineural hearing loss is accompanied by severe, inflammatory skin disorders, such as keratitis-ichthiosis-deafness (KID) syndrome. Some KID syndrome mutations result in fatality due to uncontrollable sepsis. The underlying basis of KID syndrome and other forms of syndromic deafness appears to be aberrantly behaving hemichannels, a relatively new mechanism identified among Cx-related disorders. Cx hemichannels do not participate in the formation of intercellular GJ channels, but rather remain undocked and function as large, ion channels in the plasma membrane. Mutant hemichannels have been described to behave in a "leaky" manner leading to compromised cell function and cell death. We use a combination of molecular, biophysical and imaging approaches to investigate the mechanisms by which Cx hemichannels are dysfunctional. A collaborative project uses keratinocytes isolated from transgenic mice carrying KID mutations under an inducible promoter. The mice develop normally in the absence of induction, but when induced they develop hair loss, skin lesions and show hyperproliferation of the epidermis. Maintained induction is ultimately proves fatal. We are also working towards a mouse model to study KID in the cochlea. Explants of the organ of Corti show robust GJB2 expression in the support cells that are vital for sensory transduction. Studies using such native tissues should help establish genotype-phenotype correlations for syndromic deafness and lead to strategies for treatment. Overall, we hope to also shed light on a growing list of disorders ascribed to hemichannel dysfunction that includes atherosclerosis, stroke, neuropathy and congenital cataractogenesis.
Sanchez HA, Villone K, Srinivas M and Verselis VK (2103). The D50N mutation and syndromic deafness: Altered Cx26 hemichannel properties caused by effects on the pore and intersubunit interactions. J Gen Physiol, 142:3-22.
Verselis, VK and Srinivas, M (2013). Connexin channel modulators and their mechanisms of action. Neuropharm. (Epub ahead of print).
Kronengold J, Srinivas M and Verselis VK. (2012). The N-terminal half of the connexin protein contains the essential elements of the pore and voltage gates. J. Memb. Biol. 245:453-63.
Rubinos C, Sanchez HA, Verselis VK and Srinivas M (2012). Mechanisms of inhibition of connexin channels by the quinine derivative N-benzylquininium. J Gen Physiol, 139:69-82
Sanchez HA, Mese G, Srinivas M, White TW and Verselis VK. (2010). Differentialy altered Ca2+ regulation and Ca2+ permeability in Cx26 hemichannels formed by the A40V and G45E mutations that cause keratitis-ichthyosis-deafness syndrome. J Gen Physiol, 136:47-62
Sanchez HA, Orellana JA, Verselis VK and Saez, JC (2009) Metabolic Inhibition increases the activity of connexin-32 hemichannels which are permeable to Ca2+ in transfected HeLa cells. Am J Physiol Cell Physiol, 297:C665-78
Verselis VK and Srinivas M (2008). Extracelular divalent cations selectively modulate loop gating, one of two intrinsic forms of voltage dependent gating in connexin hemichannels. J Gen Phys 132:315-27.
Chuang CF, VanHoven MK, Fetter RD, Verselis VK and Bargmann, CI. (2007). An innexin-dependent cell network establishes stochastic left-right neuronal asymmetry in C. elegans. Cell 129: 787-99.
Srinivas M, Calderon D. P., Kronengold J and Verselis VK (2006). Regulation of connexin hemichannels by monovalent cations. J Gen Phys 127:67-75.
Bukauskas FF, Kreuzberg MM, Rackauskas M, Bukauskiene A, Bennett MVL, Verselis VK and Willecke K (2006). Properties of mosue connexin 30.2 and human connexin 31.9 hemichannel: Implications for atrioventricular conduction in the heart. Proc Nat Acad Sci (USA) 103:9726-31.
Kronengold J, Trexler EB, Bukauskas FF, Bargiello TA and Verselis VK (2003). Single-channel SCAM identifies pore-lining residues in the first extracellular loop and first transmembrane domains of Cx46 hemichannels. J Gen Physiol, 122:389-405.
Bukauskas FF, Jordan K, Bukauskiene A, Bennett MVL, Lampe PD, Laird DW and Verselis VK (2000). Clustering of connexin 43-enhanced green fluorescent protein gap junction channels and functional coupling in living cells. Proc Nat Acad Sci (USA), 97:2556-2561.
Trexler EB, Bennett MVL, Bargiello TA andVerselis VK (1996). Voltage gating and permeation in a gap junction hemichannel. Proc Nat Acad Sci (USA) 93:5836-5841
Verselis VK, Ginter CS and Bargiello TA (1994). Opposite voltage gating polarities of two closely related connexins. Nature 368:348-351
More Information About Dr. Vytautas Verselis
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.
Albert Einstein College of Medicine
Rose F. Kennedy Center
1410 Pelham Parkway South , Room 710
Bronx, NY 10461